Ramelteon Tablet, Film Coated
Product Images NDC 52817-235

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ramelteon (NDC 52817-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Chemicalstructure)

Chemical structure of Ramelteon, a human prescription drug. The diagram shows the molecular framework including a bicyclic moiety fused to a tetrahydrofuran ring with substituents including an amide side chain.*

FDA Label Image

Image Description (Container8mg100cc)

Ramelteon Tablets 8 mg film-coated oral tablets label showing 100 tablets per container. The label includes storage instructions, dispensing information, and manufacturer TruPharma, LLC details. The NDC number 52817-235 is displayed with a barcode.*

FDA Label Image

Image Description (Container8mg30cc)

Label for Ramelteon Tablets 8 mg, oral film-coated tablets supplied by TruPharma, LLC. The label states the tablet strength is 8 mg of ramelteon, with a package count of 30 tablets. Storage instructions specify controlled room temperature and protection from moisture. The label includes a barcode and distributor/manufacturer details from TruPharma, LLC, Tampa, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.